The relative dearth of evidence
of either their efficacy or safety is an important
concern to be addressed by researchers. Multicentric
research including representative samples from
different countries in the Middle East would more
accurately estimate the true prevalence in the region.
Randomized controlled trials are also required to
document the safety and efficacy of these therapies